DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP DIN 00761826
Health Canada record
| Active ingredient(s) | DOPAMINE HYDROCHLORIDE 1.6 MG; DEXTROSE 50 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01CA04 DOPAMINE |
| Original market date | 31-Dec-1990 |
| Current status date | 31-Dec-1990 |
| Source | Health Canada DPD |
Establishment licence of the holder
Baxter Corporation — licence 100278, currently licensed, last inspection rating C (2026-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOPAMINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00761850 | DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | DOPAMINE HYDROCHLORIDE 0.8 MG; DEXTROSE 50 MG | Marketed |
| 00761834 | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | DOPAMINE HYDROCHLORIDE 3.2 MG; DEXTROSE 50 MG | Marketed |
| 00423823 | DOPAMINE HCL INJ 4% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | DOPAMINE HYDROCHLORIDE 40 MG | Cancelled Post Market |
| 00619698 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | DOPAMINE HYDROCHLORIDE 1.6 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 00782394 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | DOPAMINE HYDROCHLORIDE 3.2 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 00619701 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | DOPAMINE HYDROCHLORIDE 0.8 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 01914014 | INTROPIN INJECTION 40MG/ML | BRISTOL-MYERS SQUIBB CANADA | Solution | DOPAMINE HYDROCHLORIDE 40 MG | Cancelled Post Market |
International API supply for DOPAMINE HYDROCHLORIDE
3 valid EDQM Certificates of Suitability from 3 holders. 1 active FDA Drug Master Files.
Request a quote for DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP